Bee Vectoring Adds Dr. Claude Flueckiger to the Management Team

Press Releases |

MISSISSAUGA, ONTARIO--(Nov. 16, 2015) -


Bee Vectoring Technologies International Inc. (the "Company" or "BVT") (BEE:CA) is pleased to announce BVT Director Dr. Claude Flueckiger's expanded role with the Company as a management consultant to further assist the Company with product development, technological data review and strategic marketing.

Mr. Flueckiger has extensive experience in the agriculture industry and particularly in crop protection, as both global commercial and technical leader. He has acted as the Global Research and Development Leader, Controls, Lawn and Garden, for Syngenta AG ("Syngenta") for the past 11 years. He has successfully developed and implemented innovative Go-to-Market strategies for products and solutions that became large Syngenta businesses. Before his current role at Syngenta, he held various posts within Syngenta and was also Director of Crop Management, Fruits & Vegetables at Novartis in the USA.

Company CEO, Mr. Michael Collinson, states "Claude's extensive and extremely well respected experience in the crop protection industry with proven and tested go-to-market strategies for products is part of the Company's strategic plan for further development".

The Company grants to Mr. Flueckiger options to purchase up to 200,000 common shares. Additionally, the Company grants 75,000 options to an officer of the Company. Each option is exercisable to acquire one common share of the Company at a price of $0.43 until November 16, 2020 in accordance with the terms of the Company stock option plan.

About Bee Vectoring Technologies International Inc.

BVT has developed and owns patent-pending bee vectoring technology (consisting of a proprietary tray dispenser containing a unique carrier agent) that is designed to harmlessly utilize commercially reared bumblebees as natural delivery mechanisms for a variety of powdered mixtures comprised of organic compounds that inhibit or eliminate common crop diseases, while at the same time stimulating and enhancing the same crops. This unique and proprietary process facilitates a targeted delivery of crop controls using the simple process of bee pollination to replace traditional crop spraying, resulting in better yield, organic product and less impact on the environment without the use of water or disruptions to labour.

Additional information can be viewed at the Company's website

On Behalf of the Board of Directors of Bee Vectoring Technologies International Inc.,

Michael Collinson, President & CEO

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains certain "forward-looking statements" that involve known and unknown risks and uncertainties. All statements in this press release, other than statements of historical fact, that address events or developments that BVT expects to occur, are forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements with respect to BVT'S future plans and technologies, including the timing of such plans and technologies. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential", "indicate" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although BVT believes that the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include continued availability of capital, financing and required resources (such as human resources, equipment and/or other capital resources), and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of BVT'S management on the date the statements are made. BVT undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change, except as required by law.


Contact Information


Bee Vectoring Technologies International Inc.
Michael Collinson
President & CEO

For media enquiries or interviews, please contact:
Josh Stanbury

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…